FCGR3A and acute myeloid leukemia: For example, the CD16 × CD19 × CD22 or CD16 × CD33 × IL-15 TriKEs trigger NK cell activation, ADCC and cytokine secretion leading to the release of lytic granules against B-cell leukemia and AML cells [15,233,237,238].